---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-036936"
form_type: "8-K/A"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2026-08-11T00:16:16+00:00"
generated_at: "2026-08-11T10:11:00.086708+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals schedules Aug 13 release of Q1 FY2027 results, Aug 14 call

## Summary
- Q1 FY2027 (ended June 30, 2026) financial results to be released Thursday, August 13, 2026.
- Conference call Friday, August 14, 2026 at 11:30 AM EDT; dial-in 1-800-346-7359 (US), 1-973-528-0008 (intl), conference number 98840.
- 8-K/A amends prior notice, correcting event dates from November to August 2026.
- Stockholder questions accepted via dianne@elitepharma.com; general Qs by Aug 12, financial Qs by Aug 13, 2026.

## SEC filing metadata
- accession: 0001493152-26-036936
- form_type: 8-K/A
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2026-08-11T00:16:16+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315226036936/0001493152-26-036936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315226036936/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-036936
- JSON: https://secwatch.observer/filing/0001493152-26-036936.json
- Plain text: https://secwatch.observer/filing/0001493152-26-036936.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.